Non-endoscopic screening for Barrett's in veterans without reflux
Part of Cancer, Digestive system clinical trials.
This trial tests a new, non-endoscopic screening method for Barrett's esophagus (a condition that can lead to cancer) in veterans who do not have chronic acid reflux. It aims to find early signs of the condition using a simple swallowable device, potentially avoiding the need for a traditional endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 84 years old.
- You do not have weekly heartburn or regurgitation, and you are not on medication for acid reflux.
- You have at least three risk factors for Barrett's esophagus, such as being male, overweight, having a large waist, a history of smoking, or a family history of Barrett's or esophageal cancer.
- You have not had an upper endoscopy (EGD) in the past 10 years.
- You are not on blood thinners that cannot be stopped, and you do not have a bleeding disorder or esophageal problems like varices or strictures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects saliva (and, for some people, looks at stomach/esophagus samples) to understand how the mouth and gut “microbiome” changes over time in people with Barrett’s esophagus. It may help researchers find patterns that relate to Barrett’s esophagus and future risk.
This study aims to screen for Barrett's esophagus in people who are getting a routine colonoscopy but do not have chronic heartburn. It uses a simple, non-invasive cell collection device (EsoCheck) to see if you might have Barrett's esophagus, which can increase the risk of esophageal cancer.
This study tests a less invasive way to check for Barrett's esophagus and esophageal cancer. Instead of a standard endoscopy, they may use a sponge-on-a-string or other simpler methods, which could be more comfortable and easier for patients.
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
Hear when a new Obese Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.